Myanmar vs Sierra Leone: Treatment success rate for patients treated for MDR-TB
Myanmar
75.0%
in 2022
Sierra Leone
75.0%
in 2022
Myanmar rank
70th
Sierra Leone rank
70th
Treatment success rate for patients treated for MDR-TB over time
- Myanmar
- Sierra Leone
How they compare
Myanmar currently reports 75.0% against 75.0% in Sierra Leone, a difference of 0.0%.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Myanmar ahead.
Myanmar ranks 70th and Sierra Leone ranks 70th of 163 countries.
Myanmar has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Myanmar | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.0% | 76.0% | 2.0% | Myanmar |
| 2020s | 75.5% | 74.0% | 1.5% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Myanmar or Sierra Leone?
- Myanmar, at 75.0% against 75.0% in Sierra Leone as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Myanmar and Sierra Leone?
- 0.0%, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and Sierra Leone?
- 5 years are reported by both, from 2017 to 2022.
- How do Myanmar and Sierra Leone rank globally for treatment success rate for patients treated for mdr-tb?
- Myanmar ranks 70th and Sierra Leone ranks 70th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.